Elevated GRK2 expression and activity have been observed in metabolic disorders, including obesity and T2DM (Taguchi et al., 2011; 2012a; 2012b; 2017), suggesting that GRK2 inhibition may help restore endothelial function. The gene discussed is GRK2; the disease is metabolic disease.